Today’s evolving healthcare environment calls for more collaboration in bringing drugs to market
Michael Bonney, CEO, Cubist Pharmaceuticals
Advertisement
Articles by Michael Bonney, CEO, Cubist Pharmaceuticals
Advertisement
Latest Updated Articles
- Bringing New Science, and New Partners, Into the Drug Development Process
Published: January 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?
2
Lilly Agreement With Trump Administration Reshapes Patient Access to GLP-1 Obesity Medicines
3
Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio
4
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients
5
